Cancer, a complex group of diseases characterized by uncontrolled cell proliferation, has plagued humanity for millennia.  Early understanding was limited to clinical observation and rudimentary treatment, primarily surgical excision.  The 20th century witnessed a paradigm shift with the advent of chemotherapy and radiotherapy, offering systemic approaches to combatting the disease.  However, these treatments often exhibit significant toxicity and lack specificity, underscoring the need for more targeted therapies.  The discovery of oncogenes and tumor suppressor genes in the latter half of the century revolutionized our understanding of cancer's genetic basis, revealing its fundamentally molecular nature.  This realization laid the foundation for the burgeoning field of personalized medicine, aiming to tailor treatment strategies to individual patient characteristics.  This research paper explores the significant advances in our comprehension of the genetic underpinnings of cancer, examining the role of genomic sequencing, identification of driver mutations, and the development of targeted therapies.  We will further analyze the challenges and ethical considerations associated with implementing personalized medicine approaches in the clinic and discuss the future directions of this rapidly evolving field.